6

Detection, Identification and Evaluation of the Virulence Potential of FDA Relevant Pathogens Using: 1) Combined Real-time PCR plus Microarray Approaches, and 2) a Novel High Speed Nano-scale PCR Procedure

Larry E. Bockstahler, Ph.D. , CDRH/OST-OSEL

Daya Ranamukhaarachchi, Ph.D., CDRH/OST-OSEL

17

Semiconductor Nanocrystal Field Deployable Biosensor for Simultaneous Detection of Biological Warfare Agents including Clostridium botulinum Neurotoxins A, B, E, and F

Kun-Ho Seo, Ph.D., CFSAN

23

Decontamination of surgical and other instruments exposed to the infectious agents of transmissible spongiform encephalopathies (TSE agents or proions)

David M. Asher, M.D., CBER

29

Prioritizing sources of variability in genomic profiling data for standards and guidance development

Rosalie Elespuru, Ph.D., CDRH/OST-OSEL

33

Mass Spectrometric Screening for Protein Biomarkers to Indicate Food Animal Origin of Bacterial Pathogens

Tracie L. Williams, CFSAN

TOTAL